Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China
Immunology Letters · 2024
DOI: 10.1016/j.imlet.2024.106865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2024. Verfasst von Lufei Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Lipids, Inflammation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: To investigate the relationship between the lipid profiles of patients with primary Sjögren's syndrome (pSS) and other clinical characteristics, laboratory examination, disease activity, and inflammatory factors. In addition, the risk factors for hyperlipidemia-related complications of pSS and the effect of hydroxychloroquine (HCQ) usage on the lipid profile were incorporated into this study. METHODS: This is a single-center, retrospective study that included 367 patients who were diagnosed with pSS at Tongji Hospital, School of Medicine, Tongji University, China from January 2010 to March 2022. Initially, demographic information, clinical characteristics, medication records, and complications of the patients were gathered. A case-control analysis compared the 12 systems involvement (ESSDAI domain), clinical symptoms, and laboratory tests between pSS patients with and without dyslipidemia. A simple linear regression model was employed to investigate the relationship between serum lipid profile and inflammatory factors. Logistics regression analysis was performed to assess variables for hyperlipidemia-related complications of pSS. The paired t-test was then used to evaluate the improvement in lipid profile among pSS patients. RESULTS: 48.7 % of all pSS patients had dyslipidemia, and alterations in lipid levels were related to gender, age, and smoking status but not body mass index (BMI). Dyslipidemia is more prevalent in pSS patients who exhibit heightened autoimmunity and elevated levels of inflammation. Higher concentrations of multiple highly inflammatory factors correlate with a more severe form of dyslipidemia. Non-traditional cardiovascular risk factors may contribute to hyperlipidemia-related complications of pSS, such as increased, low complement 3 (C3) and low C4. According to our study, HCQ usage may protect against lipid-related disease in pSS. CONCLUSION: Attention should be paid to the dyslipidemia of pSS. This research aims to clarify the population portrait of pSS patients with abnormal lipid profiles and provides insights into the correlation between metabolism and inflammation in individuals with pSS and the potential role they play in the advancement of the disease. These findings provide novel avenues for further understanding the underlying mechanisms of pSS pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
- Department of Science and Research, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
- Department of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.. Electronic address: tangjp6512@126.com.
- Department of Rheumatology and Immunology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.. Electronic address: xuan2018@tongji.edu.cn.
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., Liang, Y., Pu, J., Cai, L., Gao, R., Han, F., Chang, K., Pan, S., Wu, Z., Zhang, Y., Wang, Y., Song, J., Wu, H., Tang, J., & Wang, X. (2024). Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China. Immunology Letters. https://doi.org/10.1016/j.imlet.2024.106865
Vancouver
Yang L, Liang Y, Pu J, Cai L, Gao R, Han F, et al. Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China. Immunology Letters. 2024. doi:10.1016/j.imlet.2024.106865
BibTeX
@article{Yang2024,
author = {Yang, Lufei and Liang, Yuanyuan and Pu, Jincheng and Cai, Li and Gao, Ronglin and Han, Fang and Chang, Keni and Pan, Shengnan and Wu, Zhenzhen and Zhang, Youwei and Wang, Yanqing and Song, Jiamin and Wu, Huihong and Tang, Jianping and Wang, Xuan},
title = {Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China},
journal = {Immunology Letters},
year = {2024},
doi = {10.1016/j.imlet.2024.106865}
}
EUVIMED